Webinar: Moving from preclinical to clinical-stage: Challenges & opportunities

24 Sep 2020

Time: Thursday, September 24, 2020 3:30 PM – 5:30 PM CET

Presentations & Speakers:

Value of a pre-IND interaction with the US FDA during late lead optimization: Bugworks experience
Bala Subramanian, Bugworks Research Inc.
Amicidins: Building clinical and regulatory strategies for non-traditional products to prevent and treat life-threatening infections
Michael P. Bevilacqua, Amicrobe, Inc.
Discovery and development of microbiome therapeutics using reverse translation
Matthew Henn & Chris Ford, Seres Therapeutics
Development of a multi-component toxoid vaccine for S. aureus – Regulatory challenges and opportunities
M. Javad Aman & Catherine Bernard, Integrated BioTherapeutics
Regulatory challenges for RaPID/BSI – culture-free identification and characterization of bloodstream infections
David Steinmiller, HelixBind Inc.

Moderator: Erin Duffy, CARB-X

The presentations will be followed by a Q&A session.

Register now for this live webinar including interactive Q&A session on September 24 2020, 15:30-17:30 CET (find your time zone here).

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us by email: revive@gardp.org.


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.